Alector (ALEC) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.13% |
| Dec 31, 2025 | -46.89% |
| Sep 30, 2025 | -18.92% |
| Jun 30, 2025 | -24.77% |
| Mar 31, 2025 | -25.39% |
| Dec 31, 2024 | 6.61% |
| Sep 30, 2024 | -21.01% |
| Jun 30, 2024 | -15.84% |
| Mar 31, 2024 | 33.36% |
| Dec 31, 2023 | -17.47% |
| Sep 30, 2023 | -17.19% |
| Jun 30, 2023 | 7.26% |
| Mar 31, 2023 | -14.66% |
| Dec 31, 2022 | -15.28% |
| Sep 30, 2022 | -12.27% |
| Jun 30, 2022 | 7.84% |
| Mar 31, 2022 | -11.04% |
| Dec 31, 2021 | -10.47% |
| Sep 30, 2021 | 82.04% |
| Jun 30, 2021 | -19.01% |
| Mar 31, 2021 | -14.84% |
| Dec 31, 2020 | -13.75% |
| Sep 30, 2020 | -12.70% |
| Jun 30, 2020 | -9.29% |
| Mar 31, 2020 | 101.15% |
| Dec 31, 2019 | -10.91% |
| Sep 30, 2019 | -11.04% |
| Jun 30, 2019 | -7.69% |
| Mar 31, 2019 | 373.30% |
| Dec 31, 2018 | -17.65% |
| Sep 30, 2018 | -19.29% |
| Jun 30, 2018 | -16.64% |